Bluejay Diagnostics completes enrollment in IL-6 pivotal study
Go back to Bluejay Diagnostics completes enrollment in IL-6 pivotal study| (NASDAQ: BJDX) | Delayed: 1.00 +0.09 (9.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.91 | 52 Week High | $ | |||
| Open | $0.91 | 52 Week Low | $ | |||
| Day High | $1.03 | P/E | N/A | |||
| Day Low | $0.90 | EPS | $ | |||
| Volume | 4,466,936 | |||||
